Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform
Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create...
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and...
Nucala receives EU approval for self administration by patients with severe eosinophilic asthma
GlaxoSmithKline announced that the European Commission has granted marketing authorisation for two new methods of administering Nucala (mepolizumab): a pre-filled...
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
Neuropore Therapies, Inc. announce that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative...
Dr. Reddys Laboratories announces the launch of Pregabalin Capsules in the U.S. Market
Dr. Reddy’s Laboratories Ltd, along with its subsidiaries together referred to as “Dr. Reddy’s” announced the launch of Pregabalin Capsulesa...
Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research...
Amicus Therapeutics Receives Marketing Authorization for Galafold (migalastat) for Fabry Disease in Argentina
Amicus Therapeutics announced that the Agency of Medicines, Food and Medical Devices (ANMAT) in Argentina has granted approval for the...
FDA Approves Daiichi Sankyos TURALIO pexidartinib for the Treatment of Select Patients with TGCT a Rare and Debilitating Tumor
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO as the first and only treatment for adult patients...
GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease
GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge...
New Advanced DualBeam Increases Productivity and Expands Ease-of-Use
Thermo Fisher Scientific unveiled its most advanced focused ion beam scanning electron microscope (FIB-SEM) for materials science researchers and engineers,...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.